Exparel 266 MG/20 ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQWE5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,623
Award facts
- Contract value 100% obligated
- $25,622.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $25,622.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. The delivery order was awarded on December 1, 2025, with an ultimate completion date of December 22, 2025, and carries no set-aside designation, indicating the company competed in unrestricted federal procurement. EXPAREL is a specialty surgical product used for local infiltration anesthesia, reflecting the company's role as a comprehensive pharmaceutical supplier serving Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036. The PPV-G GEN V program represents a $30.3 billion government-wide acquisition strategy designed to support recurring pharmaceutical and medical supply needs across military healthcare facilities globally. DMS Pharmaceutical Group's established performance on numerous delivery orders demonstrates its capability as a critical supplier within the federal military medical supply chain, with authorization to provide a comprehensive range of branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense operations.
Quick answers
Who was awarded contract SPE2DR26FQWE5?
SPE2DR26FQWE5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FQWE5 worth?
The government has obligated $25,623 on SPE2DR26FQWE5.
Is contract SPE2DR26FQWE5 an order under another contract?
Yes. SPE2DR26FQWE5 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWE5 competed?
The extent of competition for SPE2DR26FQWE5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award